Procter & Gamble (PG) PT Lowered to $175 at Jefferies

Jefferies analyst Kaumil Gajrawala lowered the price target on Procter & Gamble (NYSE: PG) to $175.00 (from $179.00) while maintaining a Buy rating.

The analyst commented, "P&G enters 2H with a more challenging backdrop. F3Q should clear the consensus bar, retail trends are accelerating, and consumer perceptions of key HPC categories are holding. But the duration of higher input costs is unknown. We lower our F26/F27 EPS by 1pp/4pp. Still, we think P&G remains among the best positioned in Staples to manage through the pressure. Maintain Buy"

You May Also Be Interested In

• Incyte (INCY) PT Raised to $105 at Truist Securities
• Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer